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1. Introduction 
The body temperature (Tb) of homeothermic animals is regulated 
by behavioral and autonomic responses (50).  As the autonomic 
responses, human beings induce shivering thermogenesis or activate 
metabolism in the brown adipose tissue (BAT), but only in the 
neonates (48).  Recent studies have shown that adults can also 
activate the BAT during cold exposure (67, 86, 87).  Rats show 
shivering, non-shivering thermogenesis in the BAT, and 
vasoconstriction of the tail (22).  Both human beings and rats show 
behavioral responses.  In the cold, both animals try to escape from 
the place, and seek warmer environment.  Human beings put on 
clothes or turn on air-conditioner, etc.  Rats may show a round 
posture or huddle to decrease their heat loss (22). 
The autonomic and behavioral responses are controlled, based on 
thermal inputs to the body.  It is generally accepted that the 
hypothalamus in the brain plays an important role in autonomic 
thermoregulation in the cold, although the precise central mechanism 
involved in thermoregulation remains unclear.  Among the areas in 
the hypothalamus, the medial preoptic area (MPO), the dorsomedial 
hypothalamus (DMH) and the median preoptic area (MnPO) are key 
regions in thermoregulation in cold (48).  The cold signals activate 
 3
GABA neurons in the MnPO via the dorsal horn of the vertebra and the 
external lateral part of the lateral parabrachial nucleus.  The neurons 
in the MnPO inhibit the GABAergic projection neurons in the MPO to 
the DMH.  Accordingly, the disinhibition of DMH neurons leads 
shivering (51).  In the contrast to the knowledge about the autonomic 
thermoregulatory responses, the neural mechanism of behavioral 
thermoregulation is unknown yet (65). 
In the present study, I first evaluated the effect of estrogen on the 
autonomic thermoregulation during cold exposure, i.e. tail 
vasoconstriction and thermogenesis in female rats.  In the second, I 
showed that the tail-hiding behavior is one of behavioral 
thermoregulatory processes in cold. 
 
1.1. Introduction of the systemic administration of estrogen on 
thermoregulation during a cold exposure in female rats 
Female sex hormones (i.e., estrogen and progesterone) are 
closely associated with sexual characteristics, behavior, and the 
estrus cycle.  Progesterone also has a febrile action (55), which may 
be associated with a change in Tb during the estrus cycle.  Several 
studies also indicate a possible involvement of estrogen in 
thermoregulation: peri- and postmenopausal women suffer from hot 
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flush, i.e., the sudden onset of face flushing, sweating, and hotness 
(56), a disturbance in circadian body temperature change (14), and a 
greater sensitivity to cold exposure (44).  Estrogen replacement is 
sometimes used as a treatment for hot flush (35).  A number of 
animal studies using ovariectomized rats with and without estrogen 
replacement have shown that estrogen has an effect on both 
autonomic and behavioral thermoregulation (21, 28, 29).  In contrast, 
Freedman et al. found that the plasma level of estradiol was not 
different between postmenopausal women with and without hot flush 
(20), suggesting a lesser involvement of circulating estrogen in this 
condition.  In another study, estrogen administration was found to 
have no influence on circadian body temperature rhythm in female 
rodents (37).  Consequently, it remains unclear if estrogen has an 
influence on thermoregulatory responses. Further, if it does affect 
thermoregulatory responses, the mechanism by which it does so is as 
yet unknown. 
The hypothalamus plays an important role in autonomic functions, 
including thermoregulation. The preoptic area (PO) of the 
hypothalamus in particular contains many thermosensitive neurons 
that can show altered neuronal activity in response to the local brain 
temperature (54).  The PO also contains estrogen-sensitive neurons 
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that are implicated in reproductive behaviors and endocrine responses.  
In an in vivo slice study, some thermosensitive neurons in the PO were 
observed to alter their neural activity in medium supplemented with 
estrogen (74).  Thus, estrogen may affect thermosensitivity at the 
level of the hypothalamus.  The interscapular brown adipose tissue 
(iBAT) is a thermoeffector organ involved in non-shivering 
thermogenesis (11).  The iBAT has been shown to have 
estrogen-specific macromolecular binding in the cytoplasmic fraction 
(83), which may also indicate a direct influence of estrogen on iBAT 
thermogenesis.  However, selective assessment of thermogenesis in 
the iBAT would be difficult in free-moving animals. 
The aim of the study reported here was to determine whether 
estrogen has an influence on central and peripheral responses to cold 
exposure.  These responses are involved in thermoregulation.  We 
first tested the hypothesis that, in ovariectomized rats, systemic 
administration of estrogen would change the hypothalamic and 
molecular responses in the iBAT during cold exposure. If the first 
hypothesis were found to be valid, the second hypothesis was that 
these responses in normal female rats change in direct 
correspondence with changes in circulating estrogen level during 
the estrus cycle. 
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 1.2. Introduction of the effect of hypothalamic application of 
estrogen on thermoregulation during a cold exposure in 
female rats 
It has been reported that estrogen is involved in body temperature 
regulation (6, 35, 56) in female animals and women.  Numbers of 
peri- and post-menopause women suffer from hot flush, i.e., a sudden 
onset of face flushing, sweating, and hotness with a reduction of body 
temperature.  Estrogen replacement is often used as a therapy for 
hot flush, although estrogen would not be a sole factor involved in hot 
flush.  However, it still remains unclear how estrogen affects body 
temperature and/or body temperature regulation. 
Romanovsky defined that the thermoneutral zone is the ambient 
temperature (Ta) at which animals can maintain Tb only by changing 
surface temperature of the dry heat-loss organs such as the tail in rats 
(63).  Several studies have shown that systemic administration of 
estrogen affects Tb of ovariectomized rats in slightly lower subneutral 
(42), subneutral (29), and supraneutral zones (5, 15).  In addition, 
estrogen augments heat production in the subneutral zone (29).  In 
addition, it has been reported that estrogen increases heat loss in the 
supraneutral zone (5) or decreases (15).  We also reported that Tb in 
 7
the subneutral zone differed among estrous phases and was linked 
with the plasma estrogen level (81).  However, we do not know the 
mechanism behind this.  One possible reason may be an abundance 
of estrogen receptors in the body, which would affect thermoregulation, 
e.g., in the hypothalamus and blood vessels, etc. Therefore, it is 
necessary to identify the site at which estrogen works and modulates 
thermoregulatory responses. 
Among the body sites, the hypothalamus may be implicated in the 
estrogen-induced changes in thermoregulatory responses. In 
particular, two sub-regions in the hypothalamus, i.e., the MPO in the 
PO and the DMH, seem to play a key role in thermoregulation.  Both 
the MPO and DMH have estrogen receptors (39).  The MPO is a 
thermosensitive site and sends efferent neurons to other brain sites 
involved in thermoregulation, such as DMH (50, 52, 54).  
Disinhibition of the neurons in the DMH increases sympathetic activity 
to the interscapular brown adipose tissue (iBAT) and skin vasculature, 
which are related to non-shivering thermogenesis and suppression of 
dry heat loss in cold (16).  Furthermore, Almeida et al. (2006) 
reported that DMH is involved in the activation of cold-seeking 
behavior after endotoxin injection. 
In the present study, we hypothesized that estrogen affects cold 
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responses at the level of the MPO and DMH.  To test this hypothesis, 
estrogen was locally administered to the MPO or DMH after 
ovariectomy in young female rats having no influence of longer-term 
estrogen imbalance or depletion, and its effect on Tb, expression of 
uncoupling 1 protein (UCP1) mRNA in the iBAT involved in 
non-shivering thermogenesis, and heat loss from the tail was 
assessed. 
 
1.3. Introduction of the effect of tail-hiding behavior on 
thermoregulatory responses during a cold exposure in the 
fed and fasted rats 
In homeothermic animals, body temperature is regulated by 
autonomic and behavioral processes.  For example, in cold 
environments, rats increase their metabolism by biochemically 
activating their supplies of brown fat and shivering.  The rats also try 
to escape from the cold by seeking warmer environments.  When no 
such environments are available, they decrease their heat loss by 
adopting a round posture or by huddling (22).  Although several 
studies have assessed the behavioral responses to thermoregulation 
using operant systems (1, 27), no study has evaluated how much the 
behavioral responses contribute to thermoregulation. 
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Rats use their tail as an effector organ for autonomic 
thermoregulation (23).  Amputation of the tail results in an increase in 
body temperature during heat exposure (77).  In contrast, cold 
induces the constriction of the tail vessels, which minimizes heat 
dissipation (22).  Romanovsky suggested that skin temperature of 
the tail could be an indicator in determining whether Ta is in a neutral, 
subneutral, or supraneutral range (66).  Our findings suggest that the 
tail is also an effector organ for behavioral thermoregulation (82).  
Ovariectomized rats displayed lower metabolic heat production in cold 
environments.  In addition, they increase the specific behavior of 
placing their tails underneath the trunk of their body in cold 
environments.  We termed this behavior “tail-hiding behavior” (82).  
However, it remains unclear whether this behavior contributes to 
thermoregulation.  Therefore, to understand the physiological 
significance of the tail-hiding behavior, we assessed whether it 
affected autonomic thermoregulatory responses, such as whether 
placing the tail under the body reduced metabolic heat demand or 
attenuated heat dissipation from the tail. 
Yoda et al. (85) reported that fasting activates operant 
warm-seeking/cold-escape behaviors during cold exposure in rats and 
that fasting attenuates metabolism (49).  Therefore, activation of the 
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operant behavior may result in the maintenance of body temperature 
without the activation of metabolic heat production.  Here, we 
compared the changes in metabolism and core body temperature 
between ad-lib fed (high energy availability) and fasting (low energy 
availability) rats.  The responses were also compared between rats 
where the tail-hiding behavior was prevented and in rats where the 
behavior was allowed, which was controlled by attaching specific 
devices to their tails.  We hypothesized that the tail-hiding behavior 
acts as a thermoregulatory process in cold environments and that rats 
without the ability to perform the tail-hiding behavior would not be able 
to maintain their core body temperature in the cold during fasting. 
 
2. Effect of systemic administration of estrogen on 
thermoregulation during a cold exposure in female rats 
 
2.1. Summary 
The aim of this study was to determine whether estrogen 
modulates central and peripheral responses to cold in female rats.  In 
ovariectomized female rats with and without administered estrogen [E2 
(+) and E2 (-), respectively], the counts of cFos-immunoreactive cells 
in the medial preoptic nucleus (MPO) and dorsomedial hypothalamic 
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nucleus (DMH) in the hypothalamus were greater in the E2 (+) rats 
than in the E2 (-) rats at 5ºC.  Examination of the response of normal 
female rats to exposure to 5ºC at different phases of the estrus cycle 
revealed that counts of cFos-immunoreactive cells in the MPO, DMH, 
and posterior hypothalamus and the level of uncoupling protein 1 
mRNA in the brown adipose tissues were greater in the proestrus 
phase than on day 1 of the diestrus phase.  This result was linked to 
the level of plasma estrogen.  The body temperature during cold 
exposure was higher in the E2 (+) rats than in the E2 (-) rats and was 
also higher in the proestrus phase than on day 1 of the diestrus phase.  
We conclude that estrogen may affect central and peripheral 
responses involved in thermoregulation in the cold. 
 
2.2. Method 
Ninety-one adult virgin female Wister rats (body weight 170–270 g, 
age 9 weeks; Takasugi Experimental Animals Supply, Saitama, Japan) 
were used in the study.  The rats were housed in a plastic cage (45 x 
25 x 20 cm) at ambient temperature (Ta) of 25ºC under a 12/12-h 
(light/dark) cycle (artificial lighting on at 0700 hours) and had free 
access to food and water.  All procedures were approved by the 
‘‘Guiding principles for the care and use of animals in the field of 
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physiological sciences’’ and the Institutional Animal Care and Use 
Committee, Waseda University. 
 
(1) Experiment 1: effect of 17β-estradiol on thermoregulation in 
female ovariectomized rats exposed to cold 
Rats (n = 55) underwent surgery under anesthesia with diethyl 
ether (Sigma-Aldrich, Tokyo, Japan).  A radio transmitter (15 x 30 x 8 
mm; PhysioTel, TA10TA-F40; Data Science, St. Paul, MN) for body 
core temperature (Tb) measurement was implanted in the peritoneal 
cavity through a median skin incision.  Bilateral ovariectomy was 
performed through the dorsal skin incision.  Penicillin G (1,000 U; 
Meiji Pharmaceutical, Tokyo, Japan) was injected subcutaneously to 
prevent post-surgical infection.  At least 7 days after the first surgery, 
two silastic tubes (inner diameter 1.57 mm, outer diameter 3.18 mm, 
length 30 mm; Kaneka, Osaka, Japan) containing either 17β-estradiol 
(E2; Sigma, St. Louis, MO; n = 26) or a blank (control; n = 29) were 
placed underneath the right dorsal skin under ether anesthesia.  The 
tubes were prepared, filled with 50–60 mg E2, and sealed with silicone 
glue as reported previously (40); this procedure maintained a constant 
level of E2 in the plasma.  At least 7 days after the second surgery, 
we placed a rat in a plastic cage (45 x 25 x 20 cm) in a climate 
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chamber (Program Incubator IN602W; Yamato Scientific, Tokyo, 
Japan) maintained at 25ºC, where the Tb was continuously monitored 
by telemetry.  Tb signals from the radio transmitter were obtained 
through a receiver board (model CTR86; Data-Science) at 1-min 
intervals and stored in a personal computer using a data-logging 
program (LabView; National Instruments, Austin, TX).  The accuracy 
of the value of Tb was ± 0.1ºC. At 1200 hours on the next day, the 
chamber was set at 5ºC for 2 h, or it remained at 25ºC as the control.  
We selected this time of a day because, in a normal environment, Tb is 
stable (less influence of circadian fluctuation) from 0900 to 1500 
hours(43), especially in the middle of the time window (1200–1400 
hours; observations from a preliminary study).  Following the 2-h cold 
exposure, the rat was killed with an intraperitoneal injection of 
overdose pentobarbital Na+ (50 mg/100 g body weight; Somnopentil; 
Kyoritsu Seiyaku, Tokyo, Japan).  The iBAT was removed for the later 
determination of the level of uncoupling protein 1 (UCP1) mRNA, and 
a 2-ml blood sample was taken from the left ventricular cavity to 
determine plasma levels of the sex hormones.  The sacrificed rat was 
then perfused transcardially with 20 ml of normal saline, followed by 
300 ml of 4% paraformaldehyde (4ºC, cold), and the whole brain was 
excised for immunohistochemical analysis. 
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 (2) Experiment 2: changes in thermoregulation in normal female 
rats exposed to cold during the estrus cycle 
For this experiment, we used normal female rats with a regular 
estrus cycle (n = 36) for this experiment.  These rats had surgery to 
implant the Tb radio transmitter, as carried out in Experiment 1. To 
determine the estrus cycle for each rat, a vaginal smear was taken 
every morning for at least 10 days (75).  Briefly, vaginal epithelium 
was obtained with a thin moist cotton swab, and a smear was made on 
a slide glass and stained by Giemsa’s method.  Based on the smear 
image, the estrus phase (i.e., the first day of diestrus, the second day 
of diestrus, proestrus, or estrus phases) was determined. A rat either 
in the estrus phase or at the second day of diestrus was selected and 
moved into the climate chamber as in Experiment 1.  At 0730 hours 
on the following day, a vaginal smear was again made to verify that the 
phase was either proestrus (P, n = 17) or the first day of diestrus (D1, n 
= 19).  These two phases were selected because the circulating level 
of estrogen is the highest in the P phase and the lowest in the 
D1 phase (75).  The chamber was set at 5ºC or remained at 25ºC 
from 0900 to 1100 hours. In the P phase, plasma progesterone starts 
increasing around 1300 hours due to a surge in luteinizing hormone, 
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with a peak around 1900 hours (75). We therefore selected a different 
time window in Experiment 2 (0900–1100 hours) to minimize the 
influence of plasma progesterone on thermoregulation.  In 
ovariectomized rats in Experiment 1, the difference in Tb between 
0900–1100 and 1200–1400 hours was less than 0.2ºC. Thus, we 
assumed that the influence of the difference in the time window on Tb 
was minimal. Following the cold or control exposure, the rat was killed 
in the same manner as Experiment 1. 
 
(3) Handlings and analyses of the blood, brain, and iBAT samples 
The blood was centrifuged at 4ºC and the plasma stored at 
-80ºC until assay.  The plasma levels of estradiol and progesterone 
were determined by an enzyme-linked immumosorbent assay (ELISA) 
in duplicate (Estradiol EIA kit and Progesterone EIA kit; Cayman 
Chemical, Ann Arbor, MI).   
The brain was first soaked in 4% paraformaldehyde at 4ºC 
overnight and then in 25% sucrose in phosphate buffered saline (PBS) 
for another 48 h.  The brain was frozen in crushed dry ice, and 
coronal sections (40-lm thickness) were prepared on a cryostat 
(CM1510S; Leica, Wilzlar, Germany).  The sections were rinsed with 
PBS and incubated sequentially in: (1) 0.3% hydrogen peroxide in 
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PBS with 0.3% Triton X-100 for 30 min; (2) rabbit primary anti-cFos 
polyclonal IgG (1:15,000 dilution; Calbiochem, Merck, Tokyo, Japan) 
for 12 h; (3) biotinylated donkey anti-rabbit IgG (1:1,000 dilution; 
Jackson ImmunoResearch Laboratories, West Grove, PA) for 90 min; 
(4) avidin–biotin complex (1:1,000 dilution; Vectastain Elite ABC 
standard kit; Vector Laboratories, Burlingame, CA) for another 90 min. 
After rinsing, the sections were reacted with 5% 
diaminobenzidinetetrahydrochloride (Sigma) in PBS and mounted on 
gelatin-coated glass slides.  Each slide was covered with a glass 
microcoverslip. Digital images of the dorsomedial hypothalamic 
nucleus (DMH), medial preoptic nucleus (MPO), median preoptic 
nucleus (MnPO), ventromedial hypothalamus (VMH), and posterior 
hypothalamus (PH) were captured with a CCD camera system (Digital 
Camera HC 2500 3CCD; FUJIFILM, Tokyo, Japan) mounted on a 
microscope (ECLIPSE E600; Nikon, Tokyo, Japan), which was 
controlled by imaging software (Image-Pro Plus; MediaCybernetics, 
Bethesda, MD).  The images were saved in TIFF format, and 
cFos-immunoreactive cells(cFos-IR cells) in three consecutive 
sections were manually dotted with image software (Adobe 
Photoshop; Adobe System, San Jose, CA). The counts were 
determined using image analyzing software (Image J; NIH, Bethesda, 
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MD).  The iBAT was immersed in RNA-stabilization reagent (RNA 
Later; QIAGEN, Tokyo, Japan) at 4ºC for 12 h and stored at -80ºC 
until assay.  Total RNA was extracted from the iBAT using the RNeasy 
Lipid Tissues Mini kit (QIAGEN). 
Briefly, the frozen tissue samples were thawed at room 
temperature and homogenized in lysis reagent (a monophasic solution 
of phenol and guanidine thiocyanate).  After adding chloroform, the 
homogenate was separated into aqueous and organic phases by 
centrifugation.  The RNA-containing aqueous phase was extracted, 
and ethanol was added to provide appropriate binding conditions.  
The sample was then applied onto a silica membrane.  After several 
washes, RNA was eluted in RNase-free water (Ultra Pure Water; 
Invitrogen, Tokyo, Japan).  The purity and concentration of the total 
RNA were determined by spectrophotometry at an absorbance of 260 
and 280 nm (NanoDrop ND-1000 spectrophotometer; Thermo 
Scientific, Wilmington, DE).  The extracted RNA was then subjected 
to first-stand cDNA synthesis using the PrimeScript RT reagent kit 
(TAKARABIO, Otsu, Japan).  The final volume was adjusted to 50 ll 
with EASY Dilution (TAKARABIO, Otsu, Japan) in accordance with the 
manufacturer ’s instructions.  In quantitative reverse transcription 
(RT)-PCR, diluted cDNA was added to a SYBER Premix Ex Taq 
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reactionmixture (TAKARABIO,Otsu, Japan) containing 200 nM PCR 
(forward and reverse) primers.  The oligonucleotide sequences for 
the primers were: 
UCP1: 50-TACCCAGCTGTGCAATGACCA (forward), 
50-GCACACAAACATGATGACGTTCC (reverse); 
Gapd: 50-GGCACAGTCAAGGCTGAGAATG(forward), 
50-ATGGTGGTGAAGACGCCAGTA (reverse). 
Amplification was performed using an ABI-Prism 7000 Sequence 
Detection System (Applied Biosystems, Foster City, CA).  The PCR 
amplification program consisted of an initial denaturation step for 10 s 
at 95ºC, followed by the Shuttle PCR standard protocol and 
dissociation protocol.  UCP1 mRNA levels were determined using the 
Threshold Cycle method in accordance with the manufacturer ’s 
protocol.  To standardize the level of UCP1 mRNA, glyceraldehyde- 
3-phosphate dehydrogenase (Gapd) mRNA, one of the housekeeping 
genes, was used for the reference in the same way as in a previous 
study in which the UCP1 mRNA level during cold exposure was 
assessed (78). 
 
(4) Statistical analysis 
All values are shown as the mean ± standard error (SE).  Values 
 19
for Tb were averaged every 5 min.  Differences between E2 (+) and E2 
(-) groups or those between the P and D1 groups were assessed by 
two-way analysis of variance (ANOVA; StatView; SAS, Cary, NC). A 
change in Tb from the 30-min averaged value before the 5ºC or 25ºC 
exposure (baseline value) was also evaluated.  A post hoc test to 
identify any significant difference at a specific time point was 
performed using the Tukey–Kramer method (76).  The null hypothesis 
was rejected at the level of P<0.05. 
 
2.3. Results 
(1) Body core temperature 
Figure 1 shows changes in the Tb during the exposure to 
25ºC (Fig. 1A, C) and 5ºC (Fig. 1B, D) in Experiments 1 and 2.  In 
Experiment 1, the Tb during the 25ºC exposure remained unchanged 
in the E2 (+) and E2 (-) groups, and there was no difference between 
the two groups (Fig. 1A; mean temperature 37.4 ± 0.1 and 37.5 ± 0.2º
C, respectively).  The Tb in the E2 (-) group was lower (P<0.05) than 
that in the E2 (+) group following 35–120 min of exposure to 5ºC (Fig. 
1B; 37.1 ± 0.1 and 36.7 ± 0.1ºC at 115 min, respectively).  In addition, 
the Tb in both groups decreased (P<0.05) from the baseline value [at 
40–120 and 10–120 min in the E2 (+) and E2 (-) groups, respectively]. 
 20
Tb remained stable in the P and D1 groups during the 25ºC exposure 
and was not different between the two groups in Experiment 2 (Fig. 
1C; mean temperature 37.2 ± 0.1 and 37.3 ± 0.1ºC, respectively).  
However, during the 5ºC exposure, the Tb in the P group was greater 
(P<0.05) than that in the D1 group at 80–95 min (Fig. 1D; 37.3 ± 0.1 
and 36.9 ± 0.1ºC at 90 min, respectively).  During the cold exposure, 
Tb in the P group was at the level of the baseline (mean 37.4 ± 0.2ºC); 
however, that in the D1 group was lower than the baseline level at 
90–120 min (mean P<0.05, 36.8 ± 0.2ºC). 
 
(2) Plasma levels of estradiol and progesterone 
Figure 2 shows the plasma levels of estradiol (Fig. 2A, C) and 
progesterone (Fig. 2B, D) in Experiments 1 and 2.  In Experiment 1, 
the plasma estradiol level was higher in the E2 (+) group than in the E2 
(-) group (P<0.05; 250 ± 30 and 30 ± 3 pg/ml, respectively; Fig. 2A) 
without any significant difference in the plasma progesterone level 
(2.5 ± 0.1 and 2.3 ± 0.2 ng/ml, respectively; Fig. 2B).  The estradiol 
level was higher in the P group than in the D1 group in Experiment 2 
(P<0.05; 100 ± 13 and 55 ± 5 pg/ml, respectively; Fig. 2C), but the 
progesterone level was not different between the two groups (4.6 ± 0.1 
and 4.5 ± 0.1 ng/ml, respectively; Fig. 2D).  Compared with the data 
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in Experiment 1, the estradiol level was greater (P<0.05) in the D1 
group than in the E2 (-) group, and lower (P<0.05) in the P group than 
in the E2 (+) group.  The progesterone level was greater (P<0.05) in 
the D1 group than in the E2 (-) group and also greater (P<0.05) in the P 
group than in the E2 (+) group. 
 
(3) cFos-IR cells in the hypothalamic areas 
Figure 3 shows the immunohistochemical images of cFos 
during exposure to 5ºC in Experiments 1 and 2 (Fig. 3A, B, 
respectively).  The images are obtained from the sites showing a 
difference in cFos expression in each experiment.  The counts of 
cFos-IR cells in the hypothalamic areas are summarized in Fig. 4.  In 
both experiments, the number of cFos-IR cells increased with cold 
exposure at 5ºC in the DMH, MPO, MnPO, VMH, and PH.  In 
Experiment 1, the counts of cFos IR cells following exposure to 25ºC 
were low throughout the hypothalamic areas in both the E2 (+) and E2 
(-) groups (Fig. 4A).  After the 5ºC exposure, the counts in the MPO 
(Fig. 3A: a, b) and DMH (Fig. 3A: c, d) were higher in the E2 (+) group 
than in the E2 (-) group; however, there were no differences in counts 
between the MnPO, VMH, and PH (Fig. 4B).  The counts of cFos-IR 
cells in the hypothalamic areas were not different between the P and 
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D1 groups following exposure to 25ºC in Experiment 2 (Fig. 4C). 
Although the counts in the MnPO and VMH were not different between 
the two groups after exposure to 5ºC, those in the MPO (Fig. 3B: a, b), 
DMH (Fig. 3B: c, d), and PH (Fig. 3B: e, f) were greater in the P group 
than in the D1 group (P<0.05, Fig. 4D).  We also assessed the 
localization of cFos-IR cells in the two hypothalamic areas.  The cells 
were mainly located in the middle and caudal parts of the MPO and all 
the areas in the DMH.  The pattern of the cell location in each area 
was not different between the E2 (+) and E2 (-) groups or the P and D1 
groups. 
 
(4) The UCP1 mRNA level in the interscapular brown adipose 
   tissue 
Figure 5 shows the UCP1 mRNA level in the iBAT in Experiments 
1 and 2.  In Experiment 1, the UCP1 mRNA level was not different 
between the E2 (+) and E2 (-) groups after exposure to 25ºC (Fig. 5A). 
In contrast, the level after the 5ºC exposure in the E2 (+) group was 
greater (P<0.05) than that in the E2 (-) group; however, there were no 
statistical differences in the UCP1 mRNA level between the 5 and 25º
C exposures in both groups.  The UCP1 mRNA level was not different 
between the P and D1 groups at 25ºC in Experiment 2, although at 5º
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C, the level was greater in the P group than in the D1 group (Fig. 5B). 
There was no difference in the level in the D1 group between the 5 and 
25ºC exposures; however, the level was greater (P<0.05) after 5ºC 
exposure in the P group.  After 25ºC exposure, the UCP1 mRNA level 
was not different between the E2 (+) and P groups or the E2 (-) and D1 
groups.  The level in the P group was lower than that in the E2 (+) 
group following the 5ºC exposure (P<0.05; Fig. 5A, B). 
 
2.4. Discussion 
The aim of our study was to evaluate the effect of estrogen on the 
central and peripheral responses which are known to be involved in 
metabolic thermoregulation during cold exposure.  Analyses of cFos 
expression in the hypothalamus and UCP1 mRNA level in the iBAT 
indicate that the central and peripheral tissues or organs may show 
different responses to the cold and that these may be linked with 
circulating estrogen level. 
 
(1) Experiment 1 
Tb decreased at 5ºC in both ovariectomized rats with and 
without E2, although the reduction in the E2 (+) group was smaller. 
However, a similar reduction in Tb was not observed at 5ºC in male 
 24
rats (31, 68).  Hosono et al. (29) reported that the Tb during a 3-h 
cold exposure at 4ºC was higher in ovariectomized rats with E2 than in 
those without E2.  In addition, the Tb in ovariectomized rats with E2 
became higher than the baseline level in association with metabolic 
heat production. In addition to differences in sex and/or the length of 
cold exposure, differences in progesterone level may have also 
affected Tb during the cold exposure because progesterone has a 
pyrogenic action (55).  In our study, the progesterone level in the 
ovariectomized rats was half that found in the normal rats, which may 
have resulted in the decreased Tb.  However, the progesterone level 
was not determined in the study of Hosono et al. (29). 
As previously reported, we also found that estradiol had no 
influence on Tb at 25ºC (28).  However, Fregly et al. found that Tb 
became lower following ethinyl estradiol treatment (21).  The 
experimental conditions were different between our study and that of 
Fregly et al. (21) in that in the latter the rats were restrained and Tb 
was monitored with a thermocouple in the rectum. It has been reported 
that restraint itself induces a decrease in Tb (72).  It is possible that 
estrogen may have an effect on the restraint-induced hypothermia, but 
it is not known whether estrogen affects factors associated with 
thermoregulation during restraint, such as stress and autonomic 
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responses.  Another possible reason for the difference may be that 
estrogen facilitates behavioral responses for thermoregulation in 
ovariectomized rats, resulting in the unchanged level of Tb in the 
free-moving animals at 25ºC. 
We assessed the central responses to the cold by counting 
cFos-IR cells in the hypothalamic areas, an approach widely reported 
in the literature.  The PO area is the site which sends many efferent 
neurons for thermoregulation (50) and also receives afferent neurons 
for thermoregulation (52).  The PH is involved in shivering 
thermogenesis (79), and the cold signal from the skin reaches the 
MnPO (52). The VMH and DMH involve iBAT thermogenesis (50, 53). 
The DMH has been reported to be involved in both shivering and 
non-shivering thermogenesis (79), and it receives neurons from the 
MPO (53).  In our study, exposure to cold increased the number of 
cFos-IR cells in all these areas. 
Previous studies have also found that cFos-IR cells increase in 
number in the MPO (45) and PO (8) during a cold exposure.  However, 
most thermosensitive neurons in the PO are warm-sensitive (89), and 
activation results in the inhibition of thermogenesis (90).  There is a 
specific region in the MPO that sends inhibitory signals to the DMH, 
and it is this region that is involved in the iBAT thermogenesis (53).  
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This region in the MPO is located more rostral to where we found a 
high number of cFos-IR cells following cold exposure (Fig. 3), and we 
also found fewer cFos-IR cells in this specific region.  The 
physiological meaning of MPO neural activation remains unclear; 
however, we speculate that the activation may reflect cold signals 
from the skin, which results in the suppression of the warm-sensitive 
neurons in the MPO.  An earlier study also suggested that the 
subregion in the DMH (i.e., the dorsolateral and ventromedial parts) 
separately innervates the nucleus raphe pallidus and spinal cord (30).  
However, we did find any different location of cFos-IR cells between 
the estrogen levels. 
UCP1 in the iBAT specifically converts energy to heat in the 
mitochondria (11). It has been reported that UCP1 knockout mice 
show a lower cold tolerance (18).  Two earlier studies showed that 
the UCP1 mRNA level in the iBAT increases after a 4- or 24-h cold 
exposure (12, 84).  However, in our study, the UCP1 mRNA level did 
not change after a 2-h cold exposure in both the E2 (+) and E2 (-) 
groups, which may have been related to the reduction of Tb.  In 
addition, a significant difference was not observed between the E2 (+) 
and E2 (-) groups at 25ºC.  Thus, we conclude that in our 
experimental model, E2 has little effect on thermogenic response of 
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the iBAT to the cold. E2 has been reported to increase the level of the 
α2c adrenoceptor, which partly mediates the cold-induced 
vasoconstriction of the tail artery (17).  It is possible that E2 is 
involved in the heat loss suppression in the cold, thereby affecting Tb. 
Estrogen administration increased the number of cFos-IR cells in 
the MPO and DMH after the cold exposure to a level that was more 
than 30% higher than the control level.  This increase in cFos-IR cells 
was not linked with the UCP1 mRNA level in the iBAT. Both the α- and 
β-estrogen receptors are abundant in the PO area (39), and an 
electrophysiological study (74) revealed that some neurons in the PO 
area are both thermo- and estrogen-sensitive.  In comparison, the 
DMH has only a few estrogen receptors (39).  Thus, we speculate 
that systemic 17β-estradiol augments cold-sensitivity at the PO area, 
and modulates cold responses in the DMH. Moreover, because the 
cold sensitivity in the MPO was weakened in the ovariectomized rats, 
they were unable to activate their thermoregulatory response to the 
cold, thereby decreasing Tb. 
 
(2) Experiment 2 
In Experiment 2, we examined whether the estrus cycle (i.e., 
fluctuation of sex hormones) affects body temperature and assessed 
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central and peripheral responses to cold exposure.  We especially 
looked at the involvement of estrogen.  To this end, we selected two 
parameters: estrus phase and time of day.  During the 4- or 5-day 
estrus cycle of rats, plasma estradiol level is the highest in the P 
phase and the lowest in the D1 phase (75).  In addition, to minimize 
the effect of plasma progesterone, the 2-h cold exposure was 
conducted at 0900–1100 hours, during which time window the plasma 
progesterone remains lower and there is no difference between the P 
and D1 phases (75).  There was no difference in Tb between the 
phases at 25ºC.  Marrone et al. (42) reported that the difference in Tb 
during the estrus cycle became apparent 10 h after light onset. 
However, as these researchers did not estimate the plasma 
progesterone level, Tb may have been influenced by the pyrogenic 
action of progesterone (55). 
In the cold, Tb was maintained and UCP1 mRNA level became 
greater in the P phase; these results differ from those of Experiment 1.  
Therefore, we speculate that estrogen also plays a key role in the cold 
response, although via a different metabolic mechanism.  
Endogenous estrogen with progesterone may be important in 
maintaining Tb with an increase in the iBAT activity in the cold.  A 
previous study showed that progesterone did not affect 
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thermosensitive neurons in the PO in ovariectomized rats and that 
38% of the thermosensitive neurons in the PO in ovariectomized rats 
were excited when estradiol was also added to the model system (80). 
In Experiment 2, counts of cFos-IR cells at 25ºC seemed to be 
higher than those in Experiment 1.  This result may reflect the 
difference in progesterone level between the two experimental 
systems.  However, we did not assess the statistical difference 
because the immunohistochemistry was separately conducted with 
different lots of antibodies.  Counts of cFos after the cold exposure 
became greater in the P phase; different from Experiment 1, the 
counts were also greater in the PH.  It has been reported that a 
chemical stimulation of the PH induced an increase in the iBAT 
thermogenesis (3).  Thus, the maintenance of Tb in the cold in the P 
phase is possibly associated with the response in the PH, although the 
UCP1 mRNA level was lower than that in the ovariectomized rats with 
E2. 
The results of our study show that plasma estrogen affects cFos 
expression in the hypothalamus during cold exposure when a 
pharmacological level of estrogen was systemically given to 
ovariectomized rats.  Endogenous estrogen may also affect the 
responses to the cold in normal female rats in a different manner from 
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that of systemic administrated estrogen reaching the pharmacological 
level.  Estrogen seems to affect thermoregulation via both the 
hypothalamus and iBAT; however, the mechanism remains unclear and 
needs to be clarified. 
 
3. Effect of hypothalamic application of estrogen on 
thermoregulation during a cold exposure in female rats 
 
3.1. Summary 
The present study examined the effect of the central 
administration of estrogen on responses to the cold.  Estrogen or 
cholesterol was applied locally to the medial preoptic nucleus (MPO) 
or dorsomedial hypothalamic nucleus (DMH) of the hypothalamus in 
free moving ovariectomized rats.  Forty-eight hours after the 
application, rats had 2-h exposure at 10 or 25 °C.  Body temperature 
(Tb) and the tail surface temperature (Ttai l) were continuously 
measured by telemetry and thermography, respectively.  The change 
of Tb at 10 °C from the 25 °C baseline was higher in the estrogen 
application in the MPO than that in the cholesterol application; 
however, such difference was not observed in the DMH application.  
The uncoupling 1 protein mRNA level in the interscapular brown 
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adipose tissue involved in non-shivering thermogenesis was not 
different between the estrogen and cholesterol applications in the 
MPO and DMH.  Ttai l decreased in the cold, which was greater after 
the estrogen application in the MPO than after the cholesterol 
application.  These results show that estrogen affects the MPO in 
female rats, changing Tb in the cold.  Moreover, suppression of heat 
loss from the tail may be involved in the mechanism. 
 
3.2. Method 
 
(1) Animals 
Virgin female Wister rats (n=100; bw: 190–290 g; age: 9– 
11 weeks; Takasugi Experimental Animals Supply, Saitama, 
Japan) were used in the present study.  The rats were housed in 
a stainless steel cage (45×25×20 cm) at Ta of 25 °C in a 12:12- 
h light–dark cycle (lights on at 07:00 h) and were allowed free 
access to food and water.  The Institutional Animal Care and 
Use Committee of Waseda University approved all experimental 
procedures in the present study.  The rats were divided to two groups 
and were subjected to two different experimental protocols as follows 
(Experiments 1 and 2).   
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 (2) Experiment 1: effect of local application of estrogen to 
the MPO and DMH on cold responses 
 
(2)-1. Surgery 
The rats (n=68) underwent surgery under inhalation anesthesia 
with diethyl ether (Sigma Aldrich, Tokyo, Japan).  After a medial skin 
incision, a radio transmitter (15×30×8 mm; PhysioTel, TA10TA-F40, 
Data Science, St. Paul, MN) for measuring Tb and spontaneous 
activity was implanted into the peritoneal cavity.  Bilateral 
ovariectomy was conducted via a dorsal skin incision, and penicillin G 
(1,000 U, Meiji Pharmaceutical, Tokyo, Japan) was injected s.c. to 
prevent post-surgical infection. 
At 1 week after surgery, the rats were anesthetized with i.p. 
administered pentobarbital Na+ (10 mg/100 g bw; Somnopentil, 
Kyoritsu Seiyaku, Tokyo, Japan) and placed on a stereotaxic 
apparatus for brain surgery (SR-6R; Narishige Scientific Instruments, 
Tokyo, Japan).  A hole was drilled in each rat's skull, and a 21-gauge 
stainless steel guide cannula (length 2mm) was inserted, the tip of 
which was located in the right MPO or DMH in accordance with 
stereotaxic coordinates (58): 5.0mmlateral and 0.8mmcaudal to the 
 33
bregma and 8.4mm below from the brain surface (the MPO group, 
n=36), with the samemeasurements being 5.0, 2.8, and 8.6 mm, 
respectively, in the DMH group (n=32).  The cannula was fixed to the 
skull with dental cement (Miky Red, Nissin, Kyoto, Japan) and secured 
with screws.  A dummy internal cannula was then put in place to 
avoid occlusion of the guide cannula (Fig. 6A). 
 
(2)-2. Local application of estrogen or cholesterol to the MPO 
and DMH 
At 1 week after the second operation, an internal cannula filled 
with 0.1 mg 17-β estradiol or cholesterol crystalline (Sigma, St. Louis, 
MO) was used to replace the dummy cannula for 4 h (the 
estrogen-treated and control rats, respectively) as previously reported 
(70).  Neither estradiol nor cholesterol was left in the cannula after 
the 4-h administration. One week after the first trial, the procedure 
was repeated using the other drug; i.e., when estrogen was used in 
the first trial, a cannula filled with cholesterol was applied.  The effect 
of estrogen in hypothalamus was estimated by the immunohistological 
analysis of ERα expression.  In addition, we verified that the effect of 
estrogen administration on the ERα expression disappeared 1 week 
after the administration. 
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 (2)-3. Exposure protocol and measurements 
Forty-six hours after the drug administration in the brain, each rat 
was moved from its cage to a climatic chamber (Program Incubator 
IN602W, Yamato Scientific, Tokyo, Japan) maintained at 25 °C for 2 h, 
in which Tb and spontaneous activity were continuously monitored by 
telemetry.  Spontaneous activity was estimated by the changes in the 
intensity of the telemetry signals. Signals from the radio transmitter 
were obtained through a receiver board placed underneath the cage 
(model CTR86, Data Science, St. Paul, MN) at 1-min intervals and 
stored on a personal computer using a data-logger (LabView, National 
Instruments, Austin).  Before the experiments, we calibrated the 
transmitter by immersing water at three different temperatures at 35, 
37, and 39 °C.  Ta was monitored with a thermocouple placed 10 cm 
above the bottom of in the climatic chamber. Accuracy of the Tb 
measurement was ±0.1 °C.  The chamber was then set at 10 °C for 2 
h (12:00–14:00 h, the subneutral exposure) or 25 °C.  Set at 10 °C, 
Ta reached at the level within 30 min. Ta was maintained within 
±0.5 °C of each set temperature.  After the temperature exposure, 
the rats were killed via i.p. injection of an overdose of pentobarbital 
Na+ (50 mg/100 g bw; Somnopentil, Kyoritsu Seiyaku, Tokyo, Japan).  
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The iBAT was then removed, immersed in RNA-stabilization reagent 
(RNA Later, QIAGEN, Tokyo, Japan) at 4 °C for 12 h, and stored at 
−80 °C.  A2-ml blood sample was taken from the left ventricular 
cavity and centrifuged at 4 °C, and the plasma was stored at −80 °C 
until the assay. Each rat was perfused transcardially with normal 
saline, followed by 4% paraformaldehyde, and then had their brain 
removed. 
 
(3) Experiment 2: effect of local application of estrogen to the 
MPO on heat loss from the tail 
 
(3)-1. Surgery 
Virgin female Wister rats (n=32) underwent surgery for 
ovariectomy and the implantation of a radio transmitter, and a 
stainless steel guide cannula was placed into the MPO (Fig. 6B). 17-β 
estradiol (the estrogen-treated rats, n=16) or cholesterol (the control 
rats, n=16) was administered through the cannula.  All these 
procedures were similar to those performed in Experiment 1. 
 
(3)-2. Exposure protocol and measurement 
Each rat was placed in a chamber: a polyethylene pail (20×32×14 
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cm) placed in a larger pail (diameter, 38 cm; height, 42 cm).  Water 
was then added to the space between the two pails and was circulated 
to and from a temperature-controlled reservoir.  Ta was monitored 
with a thermocouple placed 10 cm above the bottom of the chamber, 
and was set to 25 °C for the first 2 h (10:00 to 12:00 h) and 10 or 25 °C 
for the following 2 h (12:00 to 14:00 h). Set at 10 °C, Ta reached at the 
level within 30 min.  Ta was maintained within ± 1.0 °C of each set 
temperature.  Tb and tail surface temperatures were monitored by 
telemetry and infrared thermography (Neo Thermo TVS-700, Nihon 
Avionics, Tokyo, Japan), respectively, at 1-min intervals.  Based on 
the thermograms, tail surface temperature was analyzed at two points 
(one-third of the tail length from the tail tip and root) and then 
averaged (Ttai l).  When the tail could not be seen, the missing Ttai l 
value was replaced with that of the previous time point.  During cold 
exposure, the rats occasionally hid their tails underneath their bodies.  
We named this response “ tail-hiding behavior” and calculated the 
total duration that the behavior was observed. 
After the measurements, the rats were killed and perfused 
transcardially as in Experiment 1.  The whole brain was excised to 
verify the site of the cannula, and the iBAT was then weighed. 
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(3)-3. Handling and analyses of the blood, brain, and iBAT 
Determination of plasma estradiol level 
The plasma levels of estradiol was determined by ELISA in 
duplicate (Estradiol EIA Kit and Progesterone EIA Kit, Cayman 
Chemical, Ann Arbor, MI). 
 
(3)-4. Immunohistochemistry of cFos and estrogen receptor α 
in the hypothalamic areas 
The brain was soaked in 4%paraformaldehyde at 4 °C overnight 
and 25% sucrose in PBS for another 48 h while being frozen in 
crushed dry ice.  Coronal sections were prepared with a cryostat with 
a 40-μm thickness (CM1510S, Leica, Wilzlar, Germany), and the 
sections were then rinsed with PBS and incubated overnight in 0.3% 
hydrogen peroxide in PBS mixed with 0.3% Triton X-100 for 30min and 
rabbit anti-cFos polyclonal IgG (1:15,000 dilution; PC38, Calbiochem, 
Merck, Tokyo, Japan) or rabbit anti-estrogen receptor α polyclonal 
IgG(1:10,000 dilution, Cat No. sc-542, Santa Cruz Biotechnology, 
Santa Cruz, CA).  The anti-cFos antibody was raised against 
residues 4–17 of the human peptide gene product, and the specificity 
of the labeling was tested in previous study (Gelez and Fabre-Nys, 
2006).  The anti-estrogen receptor α antagonist specifically binds to 
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the estrogen receptors α and does not show a cross-reaction with the 
estrogen receptors ß (Hou et al., 2003).  On the next day, the 
sections were incubated with biotinylated donkey anti-rabbit IgG 
(1:1,000 dilution; Jackson ImmunoResearch Laboratories, West Grove, 
PA) for 90 min and avidin-biotin complex (1:1,000 dilution; Vectastain 
Elite ABC standard kit , Vector Laboratories, Burlingame, CA) for 
another 90min, before being reacted with 5% 
diaminobenzidinetetrahydrochloride (Sigma, St. Louis, MO) in PBS 
and mounted on gelatin-coated glass slides, each of which were 
coverslipped.  Digital images of the DMH, MPO, MnPO, VMH, and PH 
were captured (Digital Camera HC 2500 3CCD, FUJIFILM, Tokyo, 
Japan; ECLIPSE E600, Nikon, Tokyo, Japan; Image-Pro Plus, Media 
Cybernetics, Bethesda, MD) and saved in TIFF format.  cFos 
immunoreactive (cFos-IR) cells in three consecutive sections in the 
right side of the brain were manually dotted with image analyzing 
software (Adobe Photoshop, Adobe System, San Jose, CA).  The 
counts were determined using image analyzing software (Image J, NIH, 
Bethesda, MD) and the averaged were calculated.  The atlas of (58) 
was used to define the position of labeled cells. 
 
(4) UCP1 mRNA analysis 
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Total RNA was extracted from the iBAT with the RNeasy Lipid 
Tissues Mini Kit (QIAGEN, Tokyo, Japan).  Briefly, the frozen tissue 
was thawed at roomtemperature and homogenized with QIAzol Lysis 
Reagent® (a monophasic solution of phenol and guanidine 
thiocyanate).  After the addition of chloroform (Sigma Aldrich, Tokyo, 
Japan), the liquid centrifuged at 12,000×g for 15 min at 4 °C after 
vigorous shaking.  Seventy-percent ethanol (Sigma Aldrich, Tokyo, 
Japan) was added to the supernatant, which was centrifuged using a 
flow-through column.  Rnase free water (Ultra PureWater, Invitrogen, 
Tokyo, Japan) was put on a membrane of the flow-through column, 
which was centrifuged to elute.  The total RNA concentration in the 
eluent was determined based on the ratio of the absorbance at 260 
and 280 nm (NanoDrop ND-1000 Spectrophotometer, Thermo 
Scientific, Wilmington, DE).  Reverse transcription for the total iBAT 
RNA of 1000 ng was conducted using a reverse transcription kit 
(PrimeScript RT reagent Kit, TAKARABIO, Otsu, Japan).  
Denaturation was performed at 37 °C for 15min, followed by 85 °C for 
5 s in a thermal cycler (I Cycler, Bio-Rad Laboratories, Hercules, CA). 
To quantify the mRNA level ofUCP1,RT-PCRwas conducted using an 
RT-PCR kit (SYBER Premix Ex Taq Real Time, TAKARABIO, Otsu, 
Japan).  The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
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gene was used as the reference as in a previous report that 
determined the UCP1 mRNA level of the iBAT in the cold (Takayanagi 
et al., 2008).  The oligonucleotide sequences of the primers used 
were as follows: UCP1: 5′ -TACCCAGCTGTGCAATGACCA (forward) 
and 5′ -GCACACAAACATGATGACGTTCC (reverse); and GAPDH: 
5′ -GGCACAGTCAAGGCTGAGAATG (forward) and 5′–
ATGGTGGTGAAGACGCCAGTA (reverse).  The amplification was 
performed with an ABI-Prism 7000 Sequence Detection System 
(Applied Biosystems, Foster City, CA).  The denaturation protocol 
was 95 °C for 10 s, 95 °C for 5 s by 40 cycles, 60 °C for 32min, 95 °C 
for 15 s, 60 °C for 20 s, and 95 °C for 15 s. 
 
(5) Statistical analysis 
All values are shown as means±SE. Values for Tb, Ttail, and 
spontaneous activity were averaged every 5min.  The baseline value 
(the mean for the 30min before 10 or 25 °C exposure), changes in Tb 
and Ttai l, and changes in spontaneous activity from the baseline levels 
were calculated.  Differences between the estrogen-treated and 
control rats were assessed by two-way ANOVA with repeated 
measures (SPSS, Chicago, IL).  Differences between the MPO and 
DMH groups in each trial were assessed by two-way ANOVA. A post 
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hoc t-test was performed to identify significant differences at specific 
time points.  Differences in the counts of cFos-IR cells and the UCP1 
mRNA level in the iBAT between the estrogen-treated and control rats, 
the MPO and DMH groups, or the cold and control exposures were 
assessed by three-way ANOVA with SPSS.  Differences in the 
weights of the iBAT between the estrogen-treated and control rats or 
the 10 and 25 °C exposures were assessed by the Kruskal–Wallis test.  
The null hypothesis was rejected at the level of P<0.05. 
 
3.3. Results 
(1) Effect of local application of estrogen to the MPO and DMH 
on cold responses (Experiment 1) 
 
(1)-1. The number of estrogen receptor α immunoreactive 
cells in the MPO and plasma level of estradiol 
Fig. 6A illustrates application sites of estrogen and cholesterol in 
the MPO or DMH with 2-h 25 °C control or 10 °C exposure.  Fig. 7 
shows an immunohistochemical analysis of estrogen receptor α 
immunoreactive (ERα-IR) cells (Figs. 7A, B, and C) in the MPO.  In 
ovariectomized rats that did not receive a local estrogen 
administration, many ERα-IR cells were seen in both the central and 
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rostral parts of the MPO (Fig. 7A-a and b).  In the estrogen treated 
rats in the MPO group, ERα-IR cells were abundantly observed in the 
rostral MPO (Fig. 7B-b);however, few were present in the central part 
(Fig. 7B-a).  In the estrogen-treated rats of the DMH group, there 
were many ERα-IR cells in both the central and rostral parts (Fig. 7C-a 
and b).  The plasma estradiol level was not different between the 
control and estrogen-treated rats in Experiment 1 (57.5±11.0 and 
56.3±13.0 pg/ml, respectively). 
 
(1)-2. Change in body temperature 
Fig. 8 shows the change in Tb from the 25°C baseline during 
exposure to Ta of 25 and 10 °C in Experiment 1 (A and B, and C and D, 
respectively).  The baseline Tb was not different between the control 
and estrogen-treated rats in the MPO group (37.5±0.0 and 37.4±0.0 °C, 
respectively) or the DMH group (37.3±0.0 and 37.5±0.0 °C, 
respectively).  The change in Tb was not different between the control 
and estrogen-treated rats in the MPO (Fig. 8A) or DMH groups (Fig. 
8B) at 25 °C or the DMH group (Fig. 8D) at 10 °C.  In the MPO group, 
the change in Tb in the estrogen-treated rats at 10 °C was higher 
(P<0.05) than that in the control rats at 30–40, 50–70, and 95–100min 
(Fig. 8C), although no statistical change from the baseline was 
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observed in the two treatments. 
 
(1)-3. Change in spontaneous activity (movement in a cage) 
The change in spontaneous activity from the baseline during 
exposure to Ta of 25 and 10 °C in Experiment 1 are shown in Fig. 8 (E 
and F, and G and H, respectively).  The change in spontaneous 
activity was not different between the control and estrogen-treated 
rats in the MPO (Fig. 8E) or DMH groups (Fig. 8F) during exposure to 
Ta of 25 °C, or in the DMH group during exposure to Ta of 10 °C (Fig. 
8H).  In contrast, during exposure to Ta of 10 °C, the change in 
spontaneous activity in the MPO group was greater (P<0.05) in the 
estrogen-treated rats than in the control rats at 5–20, 100, and 120 
min (Fig. 8G). 
 
(1)-4. Counts of cFos immunoreactive (cFos-IR) cells in the 
hypothalamic areas 
Fig. 9 shows the immunohistochemical images of cFos in the 
MPO and DMH after exposure to Ta of 10 °C in Experiment 1 (A 
and B, respectively).  The counts of cFos-IR cells in the 
hypothalamus after exposure to Ta of 25 or 10 °C in Experiment 1 are 
summarized in Figs. 10 (A and B, and C and D, respectively).  In the 
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5 hypothalamic areas, i.e., the median preoptic nucleus (MnPO), MPO, 
DMH, ventromedial hypothalamus (VMH), and posterior hypothalamus 
(PH), there were no differences in the counts between the 25 and 
10 °C treatments in the control or estrogen-treated rats in either the 
MPO or DMH group.  In addition, there was no difference between the 
control and estrogen-treated rats under any environmental condition in 
any group. 
 
(1)-5. Uncoupling 1 protein (UCP1) mRNA level and the weight 
of the interscapular brown adipose tissue (iBAT) 
Fig. 11 illustrates the UCP1 mRNA level in the iBAT in Experiment 
1 (A and B, respectively).  In the MPO and DMH groups, the UCP1 
mRNA level was not different between the estrogen-treated and 
control rats after either 25 or 10 °C exposure.  On the other hand, in 
the control rats, the UCP1 mRNA level after exposure to Ta of 10 °C 
was higher (P<0.05) than that after exposure to Ta of 25 °C in both the 
MPO and DMH groups.  The weight of the iBAT was not significantly 
different between the control and estrogen-treated rats in the MPO 
group (85±20 and 85±1 mg at 25 °C and 89±18 and 50±12mg at 10 °C, 
respectively). 
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(2) Effect of local application of estrogen to the MPO on heat 
loss from the tail (Experiment 2) 
 
(2)-1. Change in tail surface temperature 
Application sites of estrogen and cholesterol in the MPO or DMH 
with 2-h 25 °C control or 10 °C exposure were shown in Fig. 6B.  The 
changes in tail surface temperature (Ttai l) from the baseline at 25 and 
10 °C are summarized in Figs. 7A and B, respectively.  The baseline 
Ttai l at 25 and 10 °C was not significantly different between the control 
and estrogen treated rats (28.3±0.7 and 28.0±0.5 °C, and 26.4±0.7 
and 28.2±0.3 °C, respectively).  Ttai l decreased during exposure to 
10 °C in both the control and estrogen-treated rats.  Although the 
change in Ttai l during exposure to 25 °C was not different between the 
control and estrogen-treated rats (Fig. 12A), that during exposure to 
10 °C was greater (P<0.05) in the estrogen-treated rats than in the 
control rats at 55–95 and 105–110min (Fig. 12B). 
 
(2)-2. Tail-hiding behavior 
Fig. 12C shows the length of time that the rats hid their tails 
underneath their bodies during exposure to 25 and 10 °C.  In both the 
control and estrogen-treated rats, the duration of hiding at 10 °C was 
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greater (P<0.05) than that at 25 °C.  However, the tail-hiding duration 
was not different between the control and estrogen-treated rats at 
either 25 or 10 °C (4±3 and 5±1min and 43±5 and 31±9 min, 
respectively). 
 
3.4. Discussion 
The goal of the present study was to understand whether the 
hypothalamic application of estrogen affects cold responses.  Our 
main finding was that, in ovariectomized rats, local administration of 
estrogen to the MPO affected the change in Tb in the cold, which 
correlates with the heat loss response of the tail.   
 
(1) Evaluation of the effective area of estrogen in the 
hypothalamus after the local application 
It would be difficult to know the local concentration of estrogen in 
the brain areas. Instead, we analyzed ERα-IR cells around the 
administration site in the MPO because it is well known that estrogen 
with higher concentration suppresses ER expression in the PO (73, 
91).  The present procedure used for the local application of estrogen 
enabled us to influence the estrogen level within a 0.7-mm radius from 
the tip of cannula.  Thus, we speculated that the direct effect of 
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estrogen was limited to a small area around the tip of the cannula. We 
also assessed whether locally administering estrogen to the MPO or 
DMH affects the plasma estrogen level.  Estrogen application in the 
MPO or DMH did not affect the plasma estrogen level and the level 
was below than the lowest level in normal rats (10, 75).  Therefore, 
the administered estrogen remained within a small area in the brain. 
 
(2) Estrogen application in the MPO changed the response of 
Tb in the cold 
In Experiment 1, we assessed the effect of the local 
administration of estrogen to the MPO and DMH on the response of Tb 
under cold conditions.  Estrogen application in the MPO affected the 
change in Tb in the cold. In contrast, the influence of estrogen 
application in the DMH was small.  Although the application sites of 
estrogen may not to be equally distributed in the MPO, we could not 
see any difference in Tb among the sites such as the rostral vs. caudal 
during the 25 or 10 °C exposure. The MPO and DMH are reported to 
be involved in thermoregulation in the cold (50).  Electrophysiological 
analysis (74) has indicated that estrogen directly affects 
thermosensitive neurons in the PO including the MPO.  As shown in a 
previous report (39), estrogen α and β receptors are abundant in the 
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PO.  On the other hand, the DMH has only a few estrogen receptors 
(39).  Our results indicate that estrogen directly affects the neurons 
in the MPO, which facilitates cold responses and changed the change 
in Tb in ovariectomized rats. 
 
(3) Estrogen application in the MPO affected the change in 
spontaneous activity in the cold 
Spontaneous activity may have contributed to the difference in the 
change in Tb because both values increased at the same time in the 
estrogen-treated rats. However, it is still disputed whether activity 
affects Tb in the cold (19, 60).  Gordon (22) suggested that activity 
affects heat production and loss simultaneously in small animals.  
Estrogen application in the MPO affects the change in activity in the 
cold, which may be involved in the increase of the change in Tb in the 
cold. 
 
(4) The number of cFos-IR cells in hypothalamic areas was 
not affected by estrogen application in the MPO 
We counted the number of cFos-IR cells in the hypothalamus, 
in which the number of cFos-IR cells was reported to increase in the 
cold (88).  Our previous study showed that the number of cFos-IR 
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cells during exposure to a temperature of 5 °C was augmented in the 
MPO and DMH in ovariectomized rats when a pharmacological level of 
estrogen was systemically administered (81).  In addition, the 
reduction of Tb in the cold was also attenuated in rats that received 
estrogen administration, as resemble to the result in the present study.  
However, in the present study, estrogen application in the MPO or 
DMH did not affect the number of cFos-IR cells in any hypothalamic 
areas despite the difference in the change in Tb in the cold. Therefore, 
exposure to 10 °C may not have been strong enough to increase the 
number of cFos-IR cells in the hypothalamus. In addition, the 
augmented cFos-IR cells observed at 5 °C in the MPO and DMH might 
not have been related to Tb changes.  It was reported that exposure 
to Ta of 4 °C increased the circulating corticosterone level as a stress 
response (71).  Some stresses such restraint and immobilization 
increase the number of cFos-IR cells in the MPO and DMH (9).  
Estrogen was also reported to increase the stress response in 
ovariectomized mice (46).  Thus, estrogen may modulate the number 
of cFos-IR cells in the hypothalamus under severe cold stress; 
however, such responses are not likely to be associated with Tb 
differences in the cold. 
 
 50
(5) UCP1 mRNA level in the iBAT was not influenced by 
estrogen application in the MPO 
We selected UCP1 in the iBAT as a molecular response to the 
cold because it closely involved in non-shivering thermogenesis in 
rodents (11).  It has been reported that the level of UCP1 mRNA in 
the iBAT increases after cold exposure: 3-h exposure at 4 °C in mice 
(12) and 3-h exposure at 4 °C (84) and 1-, 5-, 48-h exposures at 5 °C 
(63) in rats.  In contrast, we previously reported that ovariectomized 
rats showed smaller UCP1 mRNA level even after 2-h cold exposure at 
5 °C (81).  Various effects of the systemic administration of estrogen 
on UCP1 synthesis and its mRNA level have been reported (i.e., it 
increases them (59), suppresses them (61), or has no effect (41, 64).  
Estrogen application in the MPO did not change total UCP1 mRNA 
level in sampled tissue of the iBAT.  It was reported that exposure to 
the cold (4 °C for 2 h) decreased iBAT weight (47) ; however, the iBAT 
weight did not change after the cold in either estrogen or cholesterol 
application in the MPO.  Although the cold stimulus was milder than 
those in previous reports, the 2-h exposure would be long enough to 
induce the molecular response in the iBAT in normal rats.  Thus, the 
influence of estrogen in the MPO on non-shivering thermogenesis in 
the iBAT may have been small. 
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 (6) Estrogen application in the MPO suppressed heat loss 
from tail in the cold 
We also assessed the effect of local estrogen administration to 
the MPO on heat loss response by estimating tail surface temperature 
in Experiment 2 because the tail is the main effecter organ for heat 
dissipation in rats (23).  Previous studies show that systemic 
administration of estrogen decreased Ttai l in rats (7, 28) and mice (57) 
at a Ta of 24–25 °C.  However, in the present study, no such response 
was observed.  Ttai l decreased in the cold, probably due to strong 
vasoconstriction.  In addition, the estrogen application in the MPO 
augmented the response in ovariectomized rats.  Thus, the estrogen 
present in the MPO may specifically increase the vasoconstriction 
response of the tail in the cold, decreasing Ttai l and minimizing heat 
loss from the tail. 
 
(7) Tail-hiding behavior was not changed by estrogen 
application in the MPO 
In the cold, behavioral thermoregulatory responses such as 
huddling and augmented food intake are seen (Gordon, 1993).  In 
Experiment 2, we assessed tail-hiding behavior, which might be a 
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thermoregulatory response designed to suppress heat loss, because it 
is well known that the tail is involved in heat dissipation in rats 
(Gordon, 1990).  The tail-hiding behavior increased with the cold 
exposure; however, the estrogen application in the MPO did not affect 
the tail-hiding behavior, suggesting no contribution of the behavioral 
response to the difference of the change in Tb. 
 
(8) Conclusion 
The present study demonstrated that the local administration of 
estrogen to the MPO affected the change in body temperature in the 
cold. Two possible mechanisms could be involved in this response: 
increased the change in spontaneous activity and the suppression of 
heat loss from the tail.  Estrogen may affect thermoregulatory 
responses in the cold via estrogen receptors in the hypothalamus. 
 
4. Effect of tail-hiding behavior on thermoregulatory responses 
during a cold exposure in the fed and fasted rats 
 
4.1. Summary 
Rats place their tails underneath their body trunks when cold 
(tail-hiding behavior).  The aim of the present study was to determine 
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whether this behavior is necessary to maintain body temperature.  
Male Wistar rats were divided into ‘fed’ and ‘42-h fasting’ groups.  A 
one-piece tail holder (8.4 cm in length) that prevented the tail-hiding 
behavior or a three-piece tail holder (2.8 cm in length) that allowed for 
the tail-hiding behavior was attached to the tails of the rats.  The rats 
were exposed to 27ºC for 180 minutes or to 20ºC for 90 minutes 
followed by 15ºC for 90 minutes with continuous body temperature and 
oxygen consumption measurements.  Body temperature decreased 
by -1.0 ± 0.1°C at 15°C only in the rats that prevented tail-hiding 
behavior of the 42-h fasting group, and oxygen consumption increased 
at 15°C in all animals.  Oxygen consumption was not different 
between the rats that prevented tail-hiding behavior and the rats that 
allowed the behavior in the fed and 42-h fasting groups under ambient 
conditions.  These results show that the tail-hiding behavior is 
involved in thermoregulation in the cold in fasting rats. 
 
4.2. Method 
 
(1) Animals 
Male Wistar rats (n=80; body mass, 200–340 g; age, 7−9 week; 
Takasugi Experimental Animals Supply; Saitama, Japan) were used in 
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the study.  The rats were individually housed in stainless steel cages 
(22500 cm3) at a Ta of 25°C under a 12:12 h light-dark cycle (lights on 
at 07:00) and were allowed free access to food and water. 
 
(2) Surgery 
The rats underwent surgery using inhalation anesthesia with 
diethyl ether (Sigma Aldrich; Tokyo, Japan).  After making a medial 
skin incision, a radio transmitter device (15 × 30 × 8 mm; PhysioTel, 
TA10TA-F40; Data Science; St. Paul, USA), which measures body 
temperature (Tb), was implanted in the peritoneal cavity, and penicillin 
G (1,000 units; Meiji Pharmaceutical; Tokyo, Japan) was injected 
subcutaneously to prevent post-surgical infection.  The rats were not 
used in the experiments until at least 1 week after surgery. 
 
(3) Assessment of the tail-hiding behavior in the cold, and the 
influence of a tail-holder attachment on behavior 
(Experiment 1).  
We first assessed that male rats displayed the same tail-hiding 
behavior in cold environments as ovariectomized rats.  Rats (n=8) 
were individually placed in an experimental chamber that consisted of 
a plastic box (8960 cm3) inside a cylindrical box (47608 cm3).  All rats 
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were familiarized with being in the chamber three times before the 
experiment was performed.  Water was filled in the space between 
the two boxes, which was circulated with a pump connected to a 
temperature-controlled water reservoir.  Ta in the chamber was 
maintained at 27°C for 2 h (from 10:00 to 12:00 h) with the circulating 
water and was followed by varying the temperature to 15°C or 27°C for 
2 h (12:00 to 14:00 h).  Ta reached a stable level within 30 min, which 
was monitored with a thermocouple located 10 cm from the bottom of 
the chamber.  The cooling rate was maintained at a constant level.  
The accuracy of the set temperatures was ± 1.0°C.  Ta was monitored 
every 1 min.  Images of the rat in the chamber were collected at 
1-min intervals from the top of the chamber. 
We assessed the tail-hiding behavior in rats (n=12), and the 
behavior was modulated using a tail holder attachment.  Figure 1 
shows the two different types of tail holders used in the study.  One 
holder was a three-piece holder (28 mm in length; Fig. 13a), which 
allowed for the tail-hiding behavior (TA), and the other holder was a 
one-piece holder (84 mm in length; Fig. 13b), which prevented the 
tail-hiding behavior (TP).  The holders were made of a thin copper 
sheet (0.5 mm thickness) and were secured with thin fabric tape.  
One day before the experiment, a tail holder was attached to a rat’s 
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tail while the rat was under anesthesia with diethyl ether.  The next 
day, the rats were placed in the experimental chamber in the same 
manner as described.  We evaluated the tail-hiding behavior by 
counting the intervals where the tail images were missing in the last 
90 min of the experiment. 
 
(4) Evaluation of the role of the tail-hiding behavior in the cold 
(Experiment 2). 
Rats (n=64) were divided into two groups: the ad-lib fed and 42-h 
fasting groups.  Fasting began 42 h before the experiment (at 18:00 2 
days before the experiment).  All rats had free access to water.  
Each group was further divided into two subgroups depending on the 
type of tail holder that was attached (TA or TP).  The rats were placed 
in a semi-closed Plexiglas metabolic box (11655 cm3) with paper 
flakes at the bottom (Crecia; Tokyo, Japan) at 06:00, and the rats 
remained there overnight.  The box was in a climate-controlled 
chamber (Program Incubator IN602W; Yamato Scientific; Tokyo, 
Japan) that was maintained at 27°C.  On the next day, the Ta in the 
chamber was set to 20°C for 90 min (12:00 - 13:30 h) followed by 15°C 
for 90 min (13:30 - 15:00 h) or was maintained at 27°C as a control.  
Ta reached the set temperature within 30 min. 
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 (5) Measurements 
Tb measurements were collected through a receiver board (model 
CTR86, DataScience; St. Paul, USA) underneath the chambers in both 
experimental protocols and stored in a personal computer using a 
data-logging program (LabView, National Instruments; Austin, USA) at 
1-min intervals.  Ta was monitored with a thermocouple.  The 
accuracy of the Tb and Ta measurements was ± 0.1°C.  The metabolic 
box in Experiment 2 had an air inlet and outlet attached to an airflow 
system with a constant flow rate of 2100 ml/min.  The difference in 
the oxygen tension between the air in the inlet and outlet of the box 
was continuously monitored with an electrochemical oxygen analyzer 
(model LC-700E, Toray; Tokyo, Japan), and the data were stored 
every minute.  Oxygen consumption (V
．
O2) was calculated as the 
product of the difference between the oxygen tension and flow rate 
divided by the post-experimental body mass (fed and fasting groups, 
330 ± 16 and 232 ± 6 g, respectively) to the power of 0.75 
(Brody-Kleiber formula, (33)).  The data were corrected to standard 
temperature (0°C) and pressure (760 mm Hg) under dry conditions. 
In Experiment 2, we estimated the thermal resistance in each 
ambient condition as an index of the overall heat dissipation using the 
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following calculation: (Tb – Ta)/heat production (4).  Heat production 
was assessed using the V
．
O2 values and respiratory quotients at 27°C 
and 15°C during ad-lib feeding (0.89 and 0.80, respectively) and 
fasting (0.80 and 0.65, respectively; (26, 34, 38, 62). 
 
(6) Statistical analysis 
All values are shown as the mean ± SE.  The values of Tb and 
V
．
O2 were averaged every 30 min during the experiments, and the 
average in the second 30 min while the rat was at 27°C was defined as 
the baseline.  Differences in Tb and V
．
O2 among the four groups (the 
TA and TP subgroups in the fed and fasting groups, respectively) were 
assessed by a three-way ANOVA with repeated measurements (SPSS, 
IBM; Chicago, USA).  A post-hoc analysis was conducted using 
Fisher ’s t-test to identify significant differences at specific time points.  
The null hypothesis was rejected at the level of P<0.05. 
 
4.3. Results 
 
(1) Assessment of the tail-hiding behavior in the cold, and the 
influence of the tail-holder attachment on behavior 
(Experiment 1) 
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Figure 14a shows the duration that the tail hiding-behavior was 
observed.  The duration at 27°C was 0 min in rats without the tail 
holder attached (holder-free group); however, the duration increased 
at 15°C (60.0 ± 12.3 min).  The duration in the TA group also 
increased at 15°C (44.0 ± 4.0 min duration) without any differences in 
the holder-free group.  Figures 13b and 13c show Tb during exposure 
to 27°C and 15°C, respectively.  Tb was not different among the three 
groups. 
 
(2) Evaluation of the role of the tail-hiding behavior in the 
cold (Experiment 2) 
Figure 15 illustrates Tb in the fed and fasting groups in 
Experiment 2.  The value at time 0 denotes the baseline at 27°C in 
each group.  The baseline was not different between the TA and TP 
subgroups in any exposure protocol.  Tb remained unchanged during 
a 180-min exposure at 27°C in the TA and TP subgroups of each group 
(Figs. 15a and 3b).  At a Ta of 20°C and 15°C, Tb in the two 
subgroups of the fed group did not change from baseline (Fig. 15c).  
However, in the fasting group, Tb at 15°C decreased from baseline in 
the TP subgroup, which was lower than the TA subgroup (120−180 
min, Fig. 15d).  Tb in the TA subgroup of the fed group was not 
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different from the values in Experiment 1 at a given Ta.  Body mass 
decreased by 23.4 ± 0.8 g after 48 h of fasting (body mass in the fed 
group was 250 ± 3 g, and body mass in the fasting group was 253.8 ± 
7.0 g before fasting and 230 ± 6.5 g after fasting). 
 Figure 16 shows V
．
O2 in the fed and fasting groups in Experiment 
2.  The baseline was not different between the TA and TP subgroups 
in each condition.  V
．
O2 at 15°C increased from the baseline in the TA 
and TP subgroups in the fed and fasting groups, although the 
differences were not significant among the groups (Figs. 16c and 16d). 
Figure 17 illustrates the relationship between Tb and V
．
O2 during 
exposure at 20°C and 15°C in the two subgroups of the fed and fasting 
groups (Figs. 17a and 17b, respectively).  In the fed group, the 
relationship was similar between the TA and TP subgroups (Fig. 17a).  
During exposure at 20°C, Tb in both subgroups reached 36.6°C and 
displayed an increased V
．
O2, although no significant increase was 
detected (Fig. 17c).  V
．
O2 increased during exposure at 15°C without 
a decrease in Tb.  In the fasting group, the value of Tb at a given V
．
O2 
was lower in the TP group compared with the TA subgroup (Fig. 17b). 
Figure 18 shows the estimated thermal resistance in Experiment 2.  
Thermal resistance at 27°C was not different between the TA and TP 
subgroups in the fed and fasting groups.  The resistance at 20°C and 
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15°C increased from the level observed at 27°C in the two subgroups 
of the fed and fasting groups.  However, there were no differences 
among the four subgroups in the two groups. 
 
4.4. Discussion 
The goal of the study was to determine the role of the tail-hiding 
behavior in rats, which is observed during cold exposure.  We 
determined that fasting rats with the tail-hiding behavior prevented 
could not maintain their Tb in the cold.  This result indicates that the 
behavior serves a thermoregulatory process. 
 
(1) Tail-hiding behavior in male rats in the cold 
We assessed the tail-hiding behavior during cold exposure in 
male rats.  The behavior was not observed at 27°C in fed or fasting 
rats in Experiment 1; however, the duration of the tail-hiding behavior 
increased when the Ta was 15°C.  The surface area of the tail is 
approximately 7% of the total body surface area of a rat (Gordon 1993).  
Even in thermoneutral conditions, where autonomic thermoregulatory 
responses are small, the amount of heat dissipated from the tail 
surface is 20% greater than from the total body surface (Gordon 1993).  
Therefore, we assumed that the tail-hiding behavior decreased heat 
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dissipation in cold environments. 
 
(2) Thermoregulatory responses in rats with the tail holders  
The tail holders used in the study modulated the rats’ tail-hiding 
behavior, as shown in Fig. 13.  In addition, baseline Tb at 27°C was 
not different among rats with different types of tail holders or without 
the tail holder.  Therefore, the tail holders had no influence on heat 
loss from the tail at a Ta of 27°C. 
The tail-hiding behavior was less important for the fed animals 
because Tb was controlled during exposure to 20°C and 15°C (Fig. 
15c) with increases in V
．
O2, which was observed in the TA and TP 
subgroups (Fig. 16c).  The relationships between Tb and V
．
O2 in the 
cold (Fig. 17a) and thermal resistance (Fig. 18c) indicated that the 
effect of the tail-hiding behavior on thermoregulation was small during 
ad-lib feeding.  These results suggest that heat dissipation was 
suppressed by vasoconstriction of the tail skin in the TP subgroup and 
by the tail-hiding behavior in the TA subgroup, although we did not 
assess the skin temperature of the tail.   
The tail-hiding behavior was important for the fasting animals.  At 
15°C, the rats were able to maintain their Tb by employing the 
tail-hiding behavior (the TA subgroup; Fig. 15d); however, the Tb in the 
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rats that were unable to perform the tail-hiding behavior (TP subgroup) 
decreased.  These results indicate that the tail-hiding behavior is 
involved in thermoregulation in the cold during fasting. 
In contrast to the findings of a previous report (49), the baseline 
V
．
O2 at 27°C was not attenuated in the fasting group (Fig 15b).  One 
possible reason for this is the difference in Ta between the two study 
conditions.  V
．
O2 was previously assessed at a Ta of 23°C (49).  In 
addition, 65-h fasting decreased the threshold Tb for metabolic heat 
production in rats (69).  A Ta of 20°C may be cold enough to activate 
V
．
O2 in fed rats; however, it is not enough in fasting rats, which may 
have caused the observed differences in V
．
O2. 
We also expected that 42-h fasting would attenuate V
．
O2 in the cold.  
Fasting decreased shivering thermogenesis at 10°C in anesthetized 
rats (32) and decreased the weight of brown adipose tissue that is 
related to non-shivering thermogenesis (11, 24, 25).  However, in this 
study, V
．
O2 increased in the cold in the fed and fasting rats without any 
differences between the two feeding conditions and two types of tail 
holders (Figs. 16c and 16d).  It is believed that a reduction in Tb and 
Ta are factors that induce metabolic heat production.  The analysis of 
the relationship between Tb and V
．
O2 in the cold (Fig. 17b) suggests 
that a reduction in Tb has little effect on V
．
O2; however, a reduction in 
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Ta increased V
．
O2.  These phenomena may be explained by a 
reduction of the threshold of body temperature for metabolic heat 
production, as previously reported (69).  Feeding conditions affect 
thermoregulation in the cold.  In particular, fasting may blunt the 
response of metabolic heat production to a reduction in Tb.  However, 
fasting may not abolish the tail-hiding behavior, which prevents Tb 
reduction. 
Fasting is also a strong stimulus that suppresses heat loss from 
the tail, probably through vasoconstriction (49).  Because we did not 
assess the surface temperature of the tail skin, it is unknown if fasting 
rats could produce further vasoconstriction in the cold.  Thermal 
resistance during cold exposure with fasting was not different between 
the TA and TP groups (Fig. 18d).  In addition, the level was similar to 
the fed group.  These results may indicate that the level of tail 
vasoconstriction during fasting was not affected by the cold.  
Moreover, the tail-hiding behavior is necessary to prevent heat 
dissipation from the tail. 
Despite similar levels of thermal resistance and V
．
O2 between the 
fed and fasting groups, Tb only decreased in the TP subgroup in the 
fasting group.  This result may indicate that we overestimated the 
value of thermal resistance for the TP subgroup during fasting.  Tb 
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was not stable during cold exposure at 20°C and 15°C in the fasting 
group (Fig. 17b).  Therefore, heat flux was not stable, and the 
estimated resistance values were not accurate.  Although we did not 
assess behavioral responses to the cold during fasting, fasting may 
have increased the duration of the tail-hiding behavior, which prevents 
heat dissipation in the cold.  Therefore, the TP subgroup resulted in 
hypothermia because of a lack of the tail-hiding behavior.  When the 
metabolic responses are impaired, such as during fasting, the 
tail-hiding behavior may be an important mechanism of 
thermoregulation and directly affect Tb. 
The present study demonstrated that rats change their tail 
position based on the ambient temperature and their energy state to 
achieve thermoregulation.  The behavior is preserved during fasting 
and is important in maintaining body temperature, although the 
mechanism is currently unknown. 
 
(3) Limitations and future directions 
Behavioral thermoregulation is crucial for energy savings in 
humans and animals.  To assess behavioral thermoregulation in 
animals, thermal gradients (2) and operant systems (1, 13, 27) have 
been used.  However, these systems have limited utility for 
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estimating behavioral thermoregulation.  First, in the thermal 
gradient system, we cannot assess the effectiveness and/or 
behavioral response because animals stay still in their preferred 
temperature.  Second, operant behavior is not a natural behavior for 
thermoregulation.  In addition, animals need training to obtain the 
behavior and some animals fail, and there have been few studies that 
have assessed natural behaviors such as huddling in the cold (36).  
The tail-hiding behavior, which is a natural behavior, may be a simple 
indicator in assessing behavioral thermoregulation in rats. 
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7. Figure legends 
Figure 1. Changes in body core temperature (Tb) at 25ºC (A, C), and 5
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ºC (B, D) in Experiments 1 and 2, respectively. Tb is shown as the 
5-min average during a 2-h exposure at 5 or 25ºC after a 2-h baseline 
at 25ºC.  Values are given as the mean ± standard error (SE) [A n = 
25 (11 in the E2 (+) group and 14 in the E2 (-) group), B n = 30 (15 in 
the E2 (+) group and 15 in the E2 (-) group), C n = 16 (7 in the P group 
and 9 in the D1 group), D, n = 20 (10 in the P group and 10 in the D1 
group)].  *Significant difference between the E2 (+) and E2 (-) groups 
or between the P and D1 groups at P<0.05.  # Significant difference 
from the baseline value, P<0.05. E2 17β-estradiol, P proestrus, D1 first 
day of diestrus 
 
Figure 2. Plasma levels of estradiol (A, C) and progesterone (B, D) in 
Experiments 1 and 2, respectively.  Values are given as the mean ± 
SE [A n = 17 (9 in the E2 (+) group and 8 in the E2 (-) group), B n = 13 
(6 in the E2 (+) group and 7 in the E2 (-) group), C n = 36 (17 in the P 
group and 19 in the D1 group), D n = 36 (17 in the P group and 19 in 
the D1 group)].  *Significant difference between the E2 (+) and E2 (-) 
groups, or the P and D1 groups, P¥0.05.  # Significant difference 
between the E2 (+) and P groups or between the E2 (-) and D1 groups 
for circulating levels of estradiol or progesterone, P<0.05 
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Figure 3. Photo images of brain sections.  Coronal sections, 
including the MPO (A a, b) and DMH (A c, d) in Experiment 1, and the 
MPO (B a, b), DMH (B c, d), and PH (B e, f) in Experiment 2.  The rats 
were exposed to 5ºC for 2 h.  Cells stained in dark denote cFos 
immunoreactive cells.  MPO Medial preoptic nucleus, DMH 
dorsomedial hypothalamic nucleus, PH posterior hypothalamus.  The 
drawings are modified from the stereotaxic atlas (58). 
 
Figure 4. Counts of c-Fos immunoreactive cells in the hypothalamic 
areas.  Counts of cFos-IR cells in the hypothalamic areas after 25ºC 
exposure in Experiment 1 (A), 5ºC exposure in Experiment 1 (B), 25º
C exposure in Experiment 2 (C),and 5ºC exposure in Experiment 2 (D).  
Values are given as the mean ± SE [A n = 7 (4 in the E2 (+) group and 
3 in the E2 (-) group), B n = 25 (15 in the E2 (+) group and 10 in the E2 
(-) group), C n = 16 (7 in the P group and 9 in the D1 group), D n = 20 
(10 in the P group and 10 in the D1 group)].  *Significant difference 
between the E2 (+) and E2 (-) groups or the P and D1 groups, P<0.05.  
MnPO Median preoptic nucleus, VMH ventromedial hypothalamus, Ta 
ambient temperature 
 
Figure 5. Uncoupling protein 1 (UCP1) mRNA level with respect to the 
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glyceraldehyde-3-phosphate dehydrogenase (Gapd) level in the 
interscapular brown adipose tissues in Experiments 1 and 2 (A, B, 
respectively).  Values are given as the mean ± SE [A n = 34 (10 in 
the E2 (+) group and 9 in the E2 (-) group after 5ºC exposure, and 7 
in the E2 (+) group and 8 in the E2 (-) group after 25ºC exposure; B 
n = 34 (9 in the P group and 10 in the D1 group after 5ºC exposure, 
and 7 in the P group and 8 in the D1 group after 25ºC exposure].   
*Significant difference between the E2 (+) and E2 (-) groups or 
between the P and D1 groups, P<0.05.  # Significant difference 
between the P and E2 (+) groups after the 5ºC exposure, P<0.05.   
§Significant difference between the 5 and 25ºC exposure in the P 
group, P<0.05 
 
Figure 6. Estrogen and cholesterol application sites in Experiments 1 
(A) and 2 (B).  The diagrams were modified from the stereotaxic atlas 
(58) and show coronal sections including the MPO and DMH. MPO, 
Medial preoptic nucleus; DMH, dorsomedial hypothalamic nucleus. 
 
Figure 7. Images of brain sections including the central (a) and rostral 
(b) parts of the MPO in Experiment 1 (A, B, and C) are shown.  The 
dark dots indicate estrogen receptor α immunoreactive cells in 
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ovariectomized rats (A) and estrogen-treated rats in the MPO (B) and 
DMH (C) groups. MPO, medial preoptic nucleus; DMH; dorsomedial 
hypothalamic nucleus; central MPO, the central part of the MPO 
(bregma −0.8 mm); rostral MPO, the rostral part of the MPO (bregma 
−0.1 mm); OVX, ovariectomy; 3V, the third ventricle. The diagrams are 
modified from the stereotaxic atlas (58). The squares in the diagrams 
denote the area in which the image was taken. 
 
Figure 8. Changes in body temperature (Tb) from the baseline at 25 (A 
and B) and 10 °C (C and D) and changes in spontaneous activity from 
the baseline at 25 (E and F) and 10 °C (G and H) in Experiment 1.  
Values are means±SE (A, B, and D, n=16 rats each/ estrogen=8 and 
control=8; C, n=20 rats/estrogen=10 and control=10; E, F, and H, n=16 
rats each/estrogen=8 and control=8; G, n=20 rats/estrogen=10 and 
control=10).  The baseline Tb was not different between the control 
and estrogen-treated rats in the MPO group (37.5±0.0 and 37.4±0.0 °C, 
respectively) or the DMH group (37.3±0.0 and 37.5±0.0 °C, 
respectively).  *Significant difference between the estrogen-treated 
and control rats, P<0.05. The arrows in C and G indicate the time point 
at which both the change in body temperature and spontaneous 
activity increased simultaneously. 
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 Figure 9. Photoimages of brain sections. Coronal sections, including 
the MPO (A-a, b) and DMH (A-c, d) in the MPO group, and the MPO 
(B-a, b) and DMH (B-c, d) in the DMH group.  The rats were exposed 
to 10 °C for 2 h. Cells stained in dark denote cFos immunoreactive 
cells.  The drawings are modified from the stereotaxic atlas (58). 
 
Figure 10. Counts of cFos immunoreactive cells in the hypothalamus 
after exposure to 25 (A and B) and 10 °C (C and D) in Experiment 1. 
The counts were the average for 3 consequent sections. Values are 
means±SE (A and B, n=12 rats each/ estrogen=6 and control=6; C, 
n=24 rats/estrogen=12 and control=12; D, n=12 rats/estrogen=6 and 
control=6). MnPO, median preoptic nucleus; VMH, ventromedial 
hypothalamus; PH, posterior hypothalamus. 
 
Figure 11. UCP1 mRNA level with respect to GAPDH mRNA level in 
the iBAT in Experiment 1. Values are means±SE (A, n=32 rats/ 
estrogen=10 and control=10 after exposure to 10 °C, and estrogen=6 
and control=6 after exposure to 25 °C; B, n=27 rats/ estrogen=6 and 
control=10 after exposure to 10 °C, and estrogen=5 and control=6 
after exposure to 25 °C). #Significantly different between the 10 and 
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25 °C exposures, P<0.05. 
 
Figure 12. Changes in tail surface temperature (Ttai l) from the baseline 
at 25 (A) and 10 °C (B) and the time for which tail-hiding behavior was 
observed (C) in Experiment 2. Values are means±SE (A and B, n=16 
rats each/estrogen=8 and control=8; C, n=16 rats/estrogen=8 and 
control=8 after exposure to 10 °C, and n=16 rats/estrogen=8 and 
control=8 after exposure to 25 °C).  #Significantly different between 
the 10 and 25 °C exposures, P<0.05. *Significantly different between 
the estrogen-treated and control rats, P<0.05. 
 
Figure 13.  Tail-holders that allowed (TA, a) and prevented the 
tail-hiding behavior (TP, b).  The holders were constructed out of a 
thin copper sheet, which consisted of three pieces in the TA group and 
one piece in the TP group. 
 
Figure 14.  The duration that the tail-hiding behavior was observed 
(a) and core body temperature (Tb) in the last 90 min of the exposure 
at 27°C (b) and 15°C (c) in Experiment 1.  Values are the means ± SE 
(n=16; 4 in holder-free group, n=8 in the TA group, and n=8 in TP 
group).  *Significant difference between the groups, P<0.05. 
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 Figure 15.  Core body temperature (Tb) during exposure at 27°C in 
the fed and fasting groups (a and b, respectively) and at 20°C and 
15°C in the fed and fasting groups (c and d, respectively) in 
Experiment 2.  Values are the means ± SE (n=8 in the TA and TP 
subgroups in each group, respectively).  *Significant difference 
between the TA and TP subgroups, P<0.05.  #Significant difference 
from the baseline value at 0 min, P<0.05. 
 
Figure 16.  Oxygen consumption (V
．
O2) during exposure at 27°C in 
the fed and fasting groups (a and b, respectively) and at 20°C and 
15°C in the fed and fasting groups (c and d, respectively) in 
Experiment 2.  Values are the means ± SE (n=8 in the TA and TP 
subgroups in each group, respectively).  #Significant differences 
from the baseline shown at 0 min, P<0.05.   
 
Figure 17.  Relationship between the core body temperature (Tb) and 
oxygen consumption (V
．
O2) during exposure at 27°C, 20°C and 15°C in 
the fed (a) and fasting groups (b) in Experiment 2.  Each point 
represents the means ± SE for 8 rats during a 30-min recording period.  
The arrows indicate the time order (time of 0, 30, 60, 90, 120, 150 and 
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180 min).  Numbers next to symbols indicate the ambient 
temperature that the data were obtained. 
 
Figure 18.  Thermal resistance during exposure at 27°C in the fed 
and fasting groups (a and b, respectively) and at 20°C and 15°C in the 
fed and fasting groups (c and d, respectively) in Experiment 2.  
Values are the means ± SE (n=8 in the TA and TP subgroups in each 
group, respectively).  #Significant differences from the baseline 
shown at 0 min, P<0.05. 
Figure 1. Changes in body core temperature (Tb ) at 25ºC (A, C), and 5ºC (B, D) in Experiments 1 and 2 
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Figure 2. Plasma levels of estradiol (A, C) and progesterone (B, D) in Experiments 1 and 2 
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Figure 3. Photo images of brain sections.  Coronal sections, including the MPO (A a, b) and DMH (A c, d) 
in Experiment 1, and the MPO (B a, b), DMH (B c, d), and PH (B e, f) in Experiment 2 
93
020
40
60
80
100
120
140
MnPO MPO DMH VMH PH
*
*
*
0
20
40
60
80
100
120
140
MnPO MPO DMH VMH PH
Hypothalamic areas
P
D1
0
20
40
60
80
100
120
140
MnPO MPO DMH VMH PH
*
*
0
20
40
60
80
100
120
140
MnPO MPO DMH VMH PH
Hypothalamic areas
A E2(+)
E2(−)
B
C
ou
nt
s 
of
 F
os
-IR
 c
el
ls
C
ou
nt
s 
of
 F
os
-IR
 c
el
ls
C
D
Ta 25°C Ta 25°C
Ta 5°C Ta 5°C
Figure 4. Counts of c-Fos immunoreactive cells in the hypothalamic areas 
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Figure 5. Uncoupling protein 1 (UCP1) mRNA level with respect to the glyceraldehyde-3-phosphate 
dehydrogenase (Gapd) level in the interscapular brown adipose tissues in Experiments 1 and 2
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Figure 6. Estrogen and cholesterol application sites in Experiments 1 (A) and 2 (B)
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Figure 7. Images of brain sections including the central (a) and rostral (b) parts of the MPO 
in Experiment 1 (A, B, and C) 
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Figure 8. Changes in body temperature (Tb) from the baseline at 25 (A and B) and 10 °C (C and D) and 
changes in spontaneous activity from the baseline at 25 (E and F) and 10 °C (G and H) in 
Experiment 1 
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Figure 9. Photoimages of brain sections. Coronal sections, including the MPO (A-a, b) and DMH (A-c, d) 
in the MPO group, and the MPO (B-a, b) and DMH (B-c, d) in the DMH group 
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Figure 10. Counts of cFos immunoreactive cells in the hypothalamus after exposure to 25 (A and B) and 
10 °C (C and D) in Experiment 1 
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Figure 11. UCP1 mRNA level with respect to GAPDH mRNA level in the iBAT in Experiment 1 
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Figure 12. Changes in tail surface temperature (Ttail ) from the baseline at 25 (A) and 10 °C (B) and 
the time for which tail-hiding behavior was observed (C) in Experiment 2 
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Figure 13.  Tail-holders that allowed (TA, a) and prevented the tail-hiding behavior (TP, b) 
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Figure 14.  The duration that the tail-hiding behavior was observed (a) and core body temperature (Tb ) 
in the last 90 min of the exposure at 27°C (b) and 15°C (c) in Experiment 1 
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Figure 15.  Core body temperature (Tb) during exposure at 27°C in the fed and fasting groups (a and b, 
respectively) and at 20°C and 15°C in the fed and fasting groups (c and d, respectively) in 
Experiment 2 
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Figure 16.  Oxygen consumption (VO2) during exposure at 27°C in the fed and fasting groups (a and b, 
respectively) and at 20°C and 15°C in the fed and fasting groups (c and d, respectively) in 
Experiment 2 
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Figure 17.  Relationship between the core body temperature (Tb) and oxygen consumption (VO2) during 
exposure at 27°C, 20°C and 15°C in the fed (a) and fasting groups (b) in Experiment 2 
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Figure 18.  Thermal resistance during exposure at 27°C in the fed and fasting groups (a and b, respectively) 
and at 20°C and 15°C in the fed and fasting groups (c and d, respectively) in Experiment 2 
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